Piso B, Wild C
Ludwig Boltzmann Institute for Health Technology Assessment, Garnisongasse 7/20, 1090 Vienna, Austria.
Vaccine. 2009 Oct 9;27(43):5923-8. doi: 10.1016/j.vaccine.2009.07.105. Epub 2009 Aug 19.
Looking across boarders reveals that the national immunization programs of various countries differ in their vaccination schedules and decisions regarding the implementation and funding of new vaccines. The aim of this review is to identify decision aids and crucial criteria for a rational decision-making process on vaccine introduction and to develop a theoretical framework for decision-making based on available literature.
Systematic literature search supplemented by hand-search.
We identified five published decision aids for vaccine introduction and program planning in industrialized countries. Their comparison revealed an overall similarity with some differences in the approach as well as criteria. Burden of disease and vaccine characteristics play a key role in all decision aids, but authors vary in their views on the significance of cost-effectiveness analyses. Other relevant factors that should be considered before vaccine introduction are discussed to highly differing extents. These factors include the immunization program itself as well as its conformity with other programs, its feasibility, acceptability, and equity, as well as ethical, legal and political considerations. Assuming that the most comprehensive framework possible will not provide a feasible tool for decision-makers, we suggest a stepwise procedure.
Though even the best rational approach and most comprehensive evaluation is limited by remaining uncertainties, frameworks provide at least a structured approach to evaluate the various aspects of vaccine implementation decision-making. This process is essential in making consistently sound decisions and will facilitate the public's confidence in the decision and its realization.
纵观各国情况可知,不同国家的国家免疫规划在疫苗接种时间表以及新疫苗实施和资金投入的决策方面存在差异。本综述的目的是确定在引入疫苗时进行合理决策过程的决策辅助工具和关键标准,并根据现有文献制定决策理论框架。
系统文献检索辅以手工检索。
我们确定了五份已发表的关于工业化国家疫苗引入和规划的决策辅助工具。对它们的比较显示,总体上有相似之处,但在方法和标准上存在一些差异。疾病负担和疫苗特性在所有决策辅助工具中都起着关键作用,但作者们对成本效益分析重要性的看法各不相同。在引入疫苗之前应考虑的其他相关因素,在讨论程度上差异很大。这些因素包括免疫规划本身及其与其他规划的一致性、可行性、可接受性和公平性,以及伦理、法律和政治方面的考虑。假设最全面的框架也无法为决策者提供可行工具,我们建议采用逐步程序。
尽管即使是最佳的理性方法和最全面的评估也会受到剩余不确定性的限制,但框架至少提供了一种结构化方法来评估疫苗实施决策的各个方面。这一过程对于做出始终合理的决策至关重要,并将促进公众对决策及其实施的信心。